Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises PT to $64.

Friday, Feb 6, 2026 1:47 pm ET1min read
BMY--

Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises PT to $64.

Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises PT to $64.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet